Restriction fragment mass polymorphism (RFMP) was applied to pooled DNA for selecting informative single nucleotide polymorphisms (SNPs). A total of 225 coding non-synonymous SNPs (cnSNPs) from immunomodulating genes known to be involved in the pathogenesis of asthma were selected from the National Center for Biotechnology Information's (NCBI) SNP database (dbSNP). DNA samples from 200 healthy Koreans were pooled, amplified by polymerase chain reaction, digested with restriction enzymes and the fragments analysed by mass spectrometry. Only 30 of the 225 cnSNPs (13.3%) were informative, i.e. had a minor allele frequency > 10%. The percentage of informative cnSNPs varied according to the validation status of the dbSNP, being 42.3% (22/52) when validated by multiple submissions and frequency data, 8.7% (2/23) when validated by multiple submissions alone and 9.1% (3/33) when validated by frequency data alone. Most of the 112 unvalidated cnSNPs were not informative. In conclusion, the RFMP method using pooled DNA is useful in selecting informative SNPs, as also is validation status in the dbSNP.
Introduction
Large-scale single nucleotide polymorphism (SNP) analyses are known to be useful tools for understanding complex genetic diseases, such as hypertension, cardiovascular disease and asthma. This is because they are the most abundant genetic variation and are widely distributed throughout the entire genome. 1 Public databases are frequently used to identify SNPs of candidate genes for association studies of complex disorders. Public access SNP databases have been continuously expanded and updated: for example, more than 12 million reference SNPs were included in the SNP database (dbSNP) released in May 2006 by the National Center for Biotechnology Information (NCBI), Bethesda, MD, USA. It
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was recently reported that almost a third of the SNPs in the NCBI dbSNP are populationspecific or non-informative, with a minor allele frequency of < 10%. 2 Selecting informative SNPs from public databases rather than detecting new SNPs is, therefore, an important first step when conducting an association study.
With the increasing availability of validated SNPs, the capacity and cost of genotyping methods have become the main limiting factors in genome-wide association analyses. One way to overcome the limitations is to pool DNA samples 3 -5 If allele frequencies can be estimated using pooled DNA, most of the informative SNPs in the public databases could be chosen for larger-scale analyses. 6 A wide variety of methods for genotyping SNPs, with varying throughput and cost effectiveness, have been developed in recent years, 7 including restriction fragment length polymorphism, melting-curve analysis with fluorescence resonance energy transfer probe, and single base extension. We have recently devised a new genotyping method known as restriction fragment mass polymorphism (RFMP). This method is based on matrixassisted laser desorption-ionization-time-offlight (MALDI-TOF) mass spectrometry. 8, 9 The RFMP method has already been shown to be an efficient way to identify differences between wild-type and variant sequences in hepatitis B virus 10 and hepatitis C virus. 11 This technique involves polymerase chain reaction (PCR) amplification using primers to introduce restriction-enzyme recognition sites, followed by cleavage of the PCR product with restriction enzymes to produce genotype-specific oligonucleotide fragments. The restricted fragments are well separated as dual peaks by MALDI-TOF mass spectrometry, making it possible to estimate the relative frequencies of major and minor alleles.
In the present study, we evaluated the 'informativeness' of 225 publicly available SNPs in the Korean population using the RFMP method.
Subjects and methods

CONSTRUCTION OF THE DNA POOL
Peripheral blood samples were taken from unrelated healthy Korean individuals. Written informed consent was obtained from each patient and this study was approved by the institutional review board of the Asan Medical Centre. DNA was extracted from 200 µl of blood from each subject using the QIAamp ® blood kit (Qiagen, Chatsworth, CA, USA) according to the manufacturer's instructions. The DNA samples from all the subjects were then used to generate a single DNA pool, each sample in the pool having the same concentration.
THE RFMP METHOD
Polymerase chain reaction
A total of 225 coding non-synonymous SNPs (cnSNPs) from 70 immunomodulating genes known to be involved in the pathogenesis of asthma were selected from the NCBI dbSNP (available at http://www.ncbi.nlm.nih. gov/SNP) ( Table 1 ). PCR amplifications were performed in 18 µl reaction mixtures containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 0.2 mM of each deoxynucleotide triphosphate (dNTP), 10 pmol of each primer and 0.4 U of platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA, USA); 50 ng of genomic DNA was used for each PCR reaction. The sequences of the PCR forward and reverse primers used for validation of the fibroblast growth factor receptor 4 (FGFR4) gene are shown as examples in Table 2 ; the primers used for the other candidate genes can be provided on request.
Amplification conditions included initial denaturation at 94°C for 2 min, 10 cycles of SNP screening using restriction fragment mass polymorphism denaturation at 94°C for 15 s, annealing at 50°C for 15 s and extension at 72°C for 30 s, followed by 35 cycles of denaturation at 94°C for 15 s, annealing at 55°C for 15 s and extension at 72°C for 30 s.
Restriction-enzyme digestion
Restriction-enzyme digestion of the PCR products was performed by mixing the reaction mixture with 10 µl of buffer containing 50 mM potassium acetate,
Gene name
No. of cnSNPs Gene name No. of cnSNPs
1 Total 225 
MALDI-TOF mass spectrometry
Analysis of the pooled DNA was performed using a MALDI-TOF mass spectrometrybased assay (Bruker Daltonics Biflex IV, Billerica, MA, USA). Mass spectra were measured using a linear MALDI-TOF mass spectrometry workstation in a positive-ion, delayed-extraction mode. The result was analysed further only when the observed mass spectra exactly matched with the expected mass spectra. Table 2 provides an example of the expected masses for genotyping FGFR4 cnSNPs. The ratio of each peak area to the total area of both peaks was used to estimate the ratio between major and minor allele frequencies (Fig. 1 ). The mass spectra were processed using proprietary software (SpectroTYPER, Sequenom, San Diego, CA, USA) with baseline correction, peak identification and peak area calculation algorithms. Normalized peak areas were calculated as individual peak areas divided by the sum of the total peak area.
The use of MALDI-TOF mass spectrometry has previously been shown to have a lower limit of detection of 0.5% for minor allele 
Results
DNA samples were collected from 200 unrelated healthy Korean individuals. On MALDI-TOF mass spectrometry of the pooled DNA, only 23.6% (53/225) of the cnSNPs tested showed dual peaks on RFMP, while 76.4% (172/225) produced a single peak. None of the cnSNPs producing a single peak was found to be polymorphic when individual samples were genotyped. Only 13.3% (30/225) of the cnSNPs had an MAF > 10% (Table 3 ). It was noteworthy that most of the cnSNPs with a MAF < 5% did not show dual peaks.
The 225 cnSNPs were categorized according to validation status with the SNP database as follows: multiple submissions 10.2% (23/225), frequency data 14.7% (33/225), multiple submissions and frequency data 23.1% (52/225), and no validation status 49.8% (112/225). Further analysis of the MAF distribution of the 225 FIGURE 1: Sample spectra produced by the restriction fragment mass polymorphism method. The ratio of each peak area to the total area of both peaks was used to estimate the ratio between major and minor allele frequencies. In this spectra, the peaks for m/z = 4091.6 (ACTGgGTTTGTTG) and m/z = 2138.4 (ACAAACc) belonged to a major allele produced by 13 and 7 base pair fragments, respectively, whereas the peaks for m/z = 4075.6 (ACTGaGTTTGTTG) and m/z = 2153.4 (ACAAACt) belonged to a minor allele Relative intensity SNP screening using restriction fragment mass polymorphism cnSNPs according to validation status showed that about half (42.3%, 22/52) of the cnSNPs validated by multiple submission and frequency data were informative, i.e. had an MAF > 10% ( 
Discussion
Single nucleotide polymorphisms are the most abundant and widely distributed genetic variation in the human genome. 1 As complex genetic diseases are thought to be associated with multiple genetic loci, SNP analysis has been used to map the actual loci that contribute to genetic risk. 1, 12 Association studies require data on as many informative SNPs as possible to facilitate research into the biological impact of human variation. 13 There are several publicly available SNP databases; two of the largest are dbSNP (available at http://www.ncbi.nlm.nih.gov/projects/SNP) and HGVbase (available at http://hgvbase. cgb.ki.se), which together contain several million SNPs. 14 The availability of this large collection of SNPs allows researchers to use these databases for genetic association studies instead of searching for new SNPs. The selection of informative SNPs from public databases is therefore now an important step in these studies.
Of the 225 cnSNPs selected from the public database (dbSNP) used in the present study in Korean individuals, as many as 76% (172/225) were monomorphic, with only 13.3% (30/225) of the cnSNPs being informative (i.e. with an MAF > 10%). It is well known that there are ethnic differences in the allele frequency of SNPs. 15 For example, SNP studies of the TGFB1 gene have reported MAFs of 43% (dbSNP) and 26% (HGVbase) in Caucasian populations, 27% (The SNP Consortium) and 15% (dbSNP) in African-American populations, and 47% (dbSNP) in Asian populations. 16 An SNP may not be informative in a particular population even though it may be in other populations, so it is cost-effective to estimate the allele frequency of a population before performing an association study.
DNA pooling has been suggested as a way to maximize the cost effectiveness of SNP association studies. 17 Furthermore, mass spectrometry of pooled DNA has been reported to be reliable. 6, 18 Compared with an association study based on genotyping individuals, a pooled DNA association study has several advantages, including reduced reagent use, labour costs and time. In addition, since less DNA per sample is used per genotype, the sample can be tested for a greater number of SNPs. Mass spectrometry is well suited to the detection of small DNA molecules and can easily distinguish between two alleles because it produces separate peaks for each one. MALDI-TOF mass spectrometry has previously been shown accurately to estimate the relative frequencies of alleles. 18, 19 RFMP is a mass spectrometrybased method 8, 9 that has been shown to be an efficient way of identifying differences between wild-type and variant sequences in hepatitis B virus 10 and hepatitis C virus. 11 A previous study has shown that the lower limit of minor genotype detection was 0.5% and that the calculated ratio using the mean peak areas obtained from RFMP was highly correlated with the observed proportion (r 2 = 0.895). 11 This level of accuracy has also been reported by other researchers. 20 In the present study, most of the unvalidated cnSNPs from the dbSNP were not informative. It is unclear whether this is the case for synonymous or regulatory SNPs. The cnSNPs are of particular interest because they cause amino acid changes and can result in functional changes in a protein. It is possible that there may be fewer highly informative cnSNPs than synonymous SNPs in the public databases until their function has been fully elucidated. It may, therefore, be a poor use of time and money to genotype cnSNPs selected from public databases without validation. The present study, however, showed that validation status in the dbSNP can be a good guide when selecting informative SNPs; the most informative results were obtained from cnSNPs validated by multiple submission and frequency data.
In conclusion, only a small proportion of cnSNPs selected from the public database were informative with a MAF > 10% in a Korean population. It is, therefore, recommended that informative SNPs be identified before undertaking a large-scale association study. To this end, the RFMP method using a DNA pool is a cost-effective way to determine the relative frequency of SNPs and thereby select informative SNPs. The validation status of SNPs in the dbSNP is also a good guide in selecting informative SNPs.
